MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
HTG Molecular Diagnostics Cash Conversion Cycle 2011-2026 | HTGM
Annual Cash Conversion Cycle HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 104 | 96.9 | 80.9 | 44 | 46.1 | 64.8 | 164 | 226 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 226 | 44 | 103 |
Quarterly Cash Conversion Cycle HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 205 | 131 | 165 | - | 145 | 100 | 113 | - | 95.5 | 87.3 | 86.2 | - | 41.2 | 35.5 | 95.6 | - | 57.2 | 59 | 52.4 | - | 50.3 | 237 | 239 | - | 198 | 140 | 231 | - | 231 | 244 | 180 | - | 174 | 328 | 96.6 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 328 | 35.5 | 141 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 29.8 | -3.87 % | $ 321 M |  China |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
299 | - | - | $ 79.8 M | USA |
 |
BioNano Genomics
BNGO
|
225 | $ 1.13 | -3.54 % | $ 1.44 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | - | - | $ 914 M | USA |
 |
Danaher Corporation
DHR
|
83.5 | $ 219.93 | 0.09 % | $ 161 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
133 | - | - | $ 26.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 209.75 | 2.09 % | $ 23.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.51 | -5.18 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 11.07 | 1.37 % | $ 314 M |  Israel |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
Exact Sciences Corporation
EXAS
|
130 | $ 103.42 | - | $ 19.2 B | USA |
 |
Interpace Biosciences
IDXG
|
44.9 | $ 1.82 | - | $ 7.98 M | USA |
 |
Lantheus Holdings
LNTH
|
90.9 | $ 67.04 | - | $ 4.64 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 23.02 | - | $ 696 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | - | -0.62 % | $ 28.7 B |  Schweiz |
 |
Guardant Health
GH
|
49.1 | $ 106.6 | 1.65 % | $ 13.1 B | USA |
 |
NeoGenomics
NEO
|
82.3 | $ 11.47 | - | $ 1.45 B | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
81.5 | - | -0.5 % | $ 20.7 B | USA |
 |
OPKO Health
OPK
|
242 | $ 1.25 | 2.05 % | $ 868 M | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | - | -9.16 % | $ 8.49 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 32.03 | -2.72 % | $ 20 B | Niderland |
 |
IDEXX Laboratories
IDXX
|
108 | - | - | $ 53.5 B | USA |
 |
Illumina
ILMN
|
142 | $ 117.01 | -1.95 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 176.27 | - | $ 32 B | USA |
|
Biodesix
BDSX
|
41.7 | - | - | $ 1.33 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 289.4 | 1.75 % | $ 24.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 3.56 | -4.56 % | $ 1.91 M | USA |
 |
ICON Public Limited Company
ICLR
|
62 | - | - | $ 11 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
68.4 | - | -3.13 % | $ 1.19 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.23 | - | $ 5.12 M | USA |
 |
Bioventus
BVS
|
208 | $ 8.04 | - | $ 504 M | USA |